Re:Separation AgreementConsulting Agreement • November 7th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This letter sets forth the substance of the separation agreement (the “Agreement”) that Adverum Biotechnologies, Inc. (the “Company”) is offering to you to aid in your employment transition.
October 11, 2019 Peter SoparkarLetter Agreement • November 7th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This letter agreement (the “Agreement”) memorializes the employment terms for your anticipated hire by Adverum Biotechnologies, Inc. (the “Company”) in the position of Chief Legal Officer, reporting to Leone Patterson, CEO. These terms will become effective on or before October 30, 2019 or at a later date determined by mutual agreement (as applicable, the “Hire Date”).
February 28, 2019 Dr. Aaron Osborne Re: Employment Terms for Chief Medical Officer Dear Aaron,Letter Agreement • November 7th, 2019 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This letter agreement (the “Agreement”) memorializes the employment terms for your anticipated hire by Adverum Biotechnologies, Inc. (the “Company”) in the position of Chief Medical Officer reporting to Leone Patterson, Chief Executive Officer. These terms will become effective on April 1, 2019 or a date determined by mutual agreement. (as applicable, the “Hire Date”).
